FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085126429> ?p ?o ?g. }

• W2085126429 endingPage "322" @default.
• W2085126429 startingPage "315" @default.
• W2085126429 abstract "<i>Background:</i> Published reports examining the efficacy and safety of glucocorticoids for preserving renal function in immunoglobulin A nephropathy (IgAN) have yielded conflicting results. To systematically evaluate the efficacy and safety of glucocorticoids agents for IgAN, we conducted a meta-analysis of the published randomized controlled trials (RCTs). <i>Methods:</i> MEDLINE, EMBASE, the Cochrane Library and article reference lists were searched for RCTs that compared glucocorticoids with placebo and any other non-immunosuppressive agents for treating IgAN. The quality of the studies was evaluated with the method of the intention-to-treat analysis and allocation concealment, as well as with the Jadad method. Meta-analyses were performed on the outcomes of proteinuria and renal survival and adverse events in patients with IgAN. <i>Results:</i> Seven RCTs involving 386 patients were included in the review. Four RCTs reported renal survival data with Kaplan-Meier survival curves. Overall, glucocorticoid agents had statistically significant effects on improved renal survival (HR 0.20, 95% CI 0.20 to 0.39) and reduction of proteinuria (standardized mean difference SMD, –0.51; 95% CI –0.73 to –0.29) when compared with the control group. Tests for heterogeneity showed no difference in effect among the studies. In general, glucocorticoid agents were well tolerated. Patients receiving glucocorticoids therapy did not have an increased risk of development of type 2 diabetes mellitus, hypertension or Cushingoid adverse effects, while glucocorticoids were associated with a significant increase in the risk of gastrointestinal tract adverse events. <i>Conclusions:</i> The current cumulative evidence suggests that glucocorticoids have statistically significant effects on protecting renal function and reduction of proteinuria in patients with IgAN, but we should be careful for its gastrointestinal tract reaction. In general, glucocorticoids agents are a promising medication and should be investigated further." @default.
• W2085126429 created "2016-06-24" @default.
• W2085126429 creator A5001472045 @default.
• W2085126429 creator A5016048407 @default.
• W2085126429 creator A5032454574 @default.
• W2085126429 creator A5046899314 @default.
• W2085126429 creator A5051439492 @default.
• W2085126429 creator A5078949281 @default.
• W2085126429 date "2009-01-01" @default.
• W2085126429 modified "2023-10-16" @default.
• W2085126429 title "Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials" @default.
• W2085126429 cites W1275674295 @default.
• W2085126429 cites W1418015139 @default.
• W2085126429 cites W1558961956 @default.
• W2085126429 cites W1574743301 @default.
• W2085126429 cites W1986215651 @default.
• W2085126429 cites W1995321930 @default.
• W2085126429 cites W2002051261 @default.
• W2085126429 cites W2008478236 @default.
• W2085126429 cites W2008550780 @default.
• W2085126429 cites W2011932878 @default.
• W2085126429 cites W2033890227 @default.
• W2085126429 cites W2036550192 @default.
• W2085126429 cites W2038854658 @default.
• W2085126429 cites W2048522842 @default.
• W2085126429 cites W2054418276 @default.
• W2085126429 cites W2054592010 @default.
• W2085126429 cites W2067664785 @default.
• W2085126429 cites W2075642745 @default.
• W2085126429 cites W2096190752 @default.
• W2085126429 cites W2101763206 @default.
• W2085126429 cites W2105803357 @default.
• W2085126429 cites W2107328434 @default.
• W2085126429 cites W2123048854 @default.
• W2085126429 cites W2137981684 @default.
• W2085126429 cites W2150000105 @default.
• W2085126429 cites W2408087895 @default.
• W2085126429 cites W2041781062 @default.
• W2085126429 doi "https://doi.org/10.1159/000226129" @default.
• W2085126429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19546530" @default.
• W2085126429 hasPublicationYear "2009" @default.
• W2085126429 type Work @default.
• W2085126429 sameAs 2085126429 @default.
• W2085126429 citedByCount "48" @default.
• W2085126429 countsByYear W20851264292012 @default.
• W2085126429 countsByYear W20851264292013 @default.
• W2085126429 countsByYear W20851264292014 @default.
• W2085126429 countsByYear W20851264292015 @default.
• W2085126429 countsByYear W20851264292016 @default.
• W2085126429 countsByYear W20851264292017 @default.
• W2085126429 countsByYear W20851264292018 @default.
• W2085126429 countsByYear W20851264292019 @default.
• W2085126429 countsByYear W20851264292020 @default.
• W2085126429 countsByYear W20851264292022 @default.
• W2085126429 crossrefType "journal-article" @default.
• W2085126429 hasAuthorship W2085126429A5001472045 @default.
• W2085126429 hasAuthorship W2085126429A5016048407 @default.
• W2085126429 hasAuthorship W2085126429A5032454574 @default.
• W2085126429 hasAuthorship W2085126429A5046899314 @default.
• W2085126429 hasAuthorship W2085126429A5051439492 @default.
• W2085126429 hasAuthorship W2085126429A5078949281 @default.
• W2085126429 hasBestOaLocation W20851264291 @default.
• W2085126429 hasConcept C126322002 @default.
• W2085126429 hasConcept C134018914 @default.
• W2085126429 hasConcept C136524200 @default.
• W2085126429 hasConcept C142724271 @default.
• W2085126429 hasConcept C159641895 @default.
• W2085126429 hasConcept C168563851 @default.
• W2085126429 hasConcept C197934379 @default.
• W2085126429 hasConcept C204787440 @default.
• W2085126429 hasConcept C27081682 @default.
• W2085126429 hasConcept C2776478404 @default.
• W2085126429 hasConcept C2779561371 @default.
• W2085126429 hasConcept C2780091579 @default.
• W2085126429 hasConcept C2781184683 @default.
• W2085126429 hasConcept C555293320 @default.
• W2085126429 hasConcept C71924100 @default.
• W2085126429 hasConcept C95190672 @default.
• W2085126429 hasConceptScore W2085126429C126322002 @default.
• W2085126429 hasConceptScore W2085126429C134018914 @default.
• W2085126429 hasConceptScore W2085126429C136524200 @default.
• W2085126429 hasConceptScore W2085126429C142724271 @default.
• W2085126429 hasConceptScore W2085126429C159641895 @default.
• W2085126429 hasConceptScore W2085126429C168563851 @default.
• W2085126429 hasConceptScore W2085126429C197934379 @default.
• W2085126429 hasConceptScore W2085126429C204787440 @default.
• W2085126429 hasConceptScore W2085126429C27081682 @default.
• W2085126429 hasConceptScore W2085126429C2776478404 @default.
• W2085126429 hasConceptScore W2085126429C2779561371 @default.
• W2085126429 hasConceptScore W2085126429C2780091579 @default.
• W2085126429 hasConceptScore W2085126429C2781184683 @default.
• W2085126429 hasConceptScore W2085126429C555293320 @default.
• W2085126429 hasConceptScore W2085126429C71924100 @default.
• W2085126429 hasConceptScore W2085126429C95190672 @default.
• W2085126429 hasIssue "4" @default.
• W2085126429 hasLocation W20851264291 @default.
• W2085126429 hasLocation W20851264292 @default.
• W2085126429 hasOpenAccess W2085126429 @default.

• next